![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 24396 |
FusionGeneSummary for NIPBL_SLC30A9 |
![]() |
Fusion gene information | Fusion gene name: NIPBL_SLC30A9 | Fusion gene ID: 24396 | Hgene | Tgene | Gene symbol | NIPBL | SLC30A9 | Gene ID | 25836 | 10463 |
Gene name | NIPBL, cohesin loading factor | solute carrier family 30 member 9 | |
Synonyms | CDLS|CDLS1|IDN3|IDN3-B|Scc2 | BILAPES|C4orf1|GAC63|HUEL|ZNT9 | |
Cytomap | 5p13.2 | 4p13 | |
Type of gene | protein-coding | protein-coding | |
Description | nipped-B-like proteinNipped-B homologSCC2 homologdelanginsister chromatid cohesion 2 homolog | zinc transporter 9GRIP1-dependent nuclear receptor coactivatorexpressed in human embryonic lunghuman embryonic lung proteinsolute carrier family 30 (zinc transporter), member 9znT-9 | |
Modification date | 20180527 | 20180519 | |
UniProtAcc | Q6KC79 | Q6PML9 | |
Ensembl transtripts involved in fusion gene | ENST00000282516, ENST00000448238, ENST00000504430, | ENST00000264451, | |
Fusion gene scores | * DoF score | 18 X 9 X 11=1782 | 3 X 5 X 3=45 |
# samples | 24 | 4 | |
** MAII score | log2(24/1782*10)=-2.8923910259134 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/45*10)=-0.169925001442312 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NIPBL [Title/Abstract] AND SLC30A9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NIPBL | GO:0000122 | negative regulation of transcription by RNA polymerase II | 18854353 |
Hgene | NIPBL | GO:0031065 | positive regulation of histone deacetylation | 18854353 |
Hgene | NIPBL | GO:0045892 | negative regulation of transcription, DNA-templated | 18854353 |
Hgene | NIPBL | GO:0071921 | cohesin loading | 22628566 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-A7-A6VV-01A | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42062208 | + |
TCGA | LD | BRCA | TCGA-A7-A6VV-01A | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42065003 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000282516 | ENST00000264451 | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42062208 | + |
5UTR-3CDS | ENST00000448238 | ENST00000264451 | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42062208 | + |
intron-3CDS | ENST00000504430 | ENST00000264451 | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42062208 | + |
5UTR-3CDS | ENST00000282516 | ENST00000264451 | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42065003 | + |
5UTR-3CDS | ENST00000448238 | ENST00000264451 | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42065003 | + |
intron-3CDS | ENST00000504430 | ENST00000264451 | NIPBL | chr5 | 36877280 | + | SLC30A9 | chr4 | 42065003 | + |
Top |
FusionProtFeatures for NIPBL_SLC30A9 |
![]() |
Hgene | Tgene |
NIPBL | SLC30A9 |
Plays an important role in the loading of the cohesincomplex on to DNA. Forms a heterodimeric complex (also known ascohesin loading complex) with MAU2/SCC4 which mediates the loadingof the cohesin complex onto chromatin (PubMed:22628566,PubMed:28914604). Plays a role in cohesin loading at sites of DNAdamage. Its recruitement to double-strand breaks (DSBs) sitesoccurs in a CBX3-, RNF8- and RNF168-dependent manner whereas itsrecruitement to UV irradiation-induced DNA damage sites occurs ina ATM-, ATR-, RNF8- and RNF168-dependent manner (PubMed:28167679).Along with ZNF609, promotes cortical neuron migration during braindevelopment by regulating the transcription of crucial genes inthis process. Preferentially binds promoters containing paused RNApolymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1and GABBR2 genes, among others (By similarity).{ECO:0000250|UniProtKB:Q6KCD5, ECO:0000269|PubMed:22628566,ECO:0000269|PubMed:28167679, ECO:0000269|PubMed:28914604}. | Acts as a zinc transporter involved in intracellularzinc homeostasis (PubMed:28334855). Functions as a secondarycoactivator for nuclear receptors by cooperating with p160coactivators subtypes. Plays a role in transcriptional activationof Wnt-responsive genes (By similarity).{ECO:0000250|UniProtKB:Q5IRJ6, ECO:0000269|PubMed:28334855}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NIPBL_SLC30A9 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NIPBL_SLC30A9 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NIPBL | PRSS23, CBX5, SP100, CBX3, MLLT3, SMC1A, SMC3, MED23, CDK8, SIRT7, HINFP, TOMM40, PPT1, SF3A2, RAD21, MAU2, CDK6, RPA3, RPA2, RPA1, BRCA1, OBSL1, CCDC8, EED, EWSR1, RPL10, TFG, LDHD, SUCO, USP37, SNW1, CDC5L, ARFGAP1, TRIM25 | SLC30A9 | ELAVL1, DHX15, HLA-DQA1, SPDEF, COPS5, VSIG4, ERGIC3, HERC2, C6orf203, COX5A, VNN2, TBC1D15 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NIPBL_SLC30A9 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NIPBL_SLC30A9 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NIPBL | C0270972 | Cornelia De Lange Syndrome | 9 | CTD_human;ORPHANET;UNIPROT |
Hgene | NIPBL | C0005941 | Bone Diseases, Developmental | 1 | CTD_human |
Hgene | NIPBL | C0018798 | Congenital Heart Defects | 1 | CTD_human |
Hgene | NIPBL | C0260662 | Hearing problem | 1 | CTD_human |
Hgene | NIPBL | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |